Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED reports fourth-quarter revenue of $2.07 billion, compared to Street Est’s $2.007 billion







Newswires MT 2022

All the news from VERTEX PHARMACEUTICALS

Analyst recommendations on VERTEX PHARMACEUTICALS

Sales 2021 7,502 million

Net income 2021 2,295 million

Net cash 2021 8,192 million

PER 2021 ratio 25.8x
2021 performance
Capitalization 57,743 million
57,743 million
EV / Sales 2021 6.61x
EV / Sales 2022 5.57x
# of employees 3,400
Floating

Chart VERTEX PHARMACEUTICALS


Duration :

Period :




Vertex Pharmaceuticals Technical Analysis Chart |  MarketScreener

Technical Analysis Trends VERTEX PHARMACEUTICALS

Short term Middle term Long term
Tendencies Bullish Bullish Bullish



Evolution of the income statement

To sell

To buy

Medium consensus SURPASS
Number of analysts 27
Last closing price

$227.11

Average target price

$268.39

Average Spread / Target 18.2%


Comments are closed.